Artemis Global

Artemis-Global-Life-Sciences-Ltd23 Oct 2019

Healthcare

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Artemis Global

Artemis Global

Healthcare

Artemis-Global-Life-Sciences-Ltd23 Oct 2019

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
15-Oct-2019	BC	Amalgamation	25-Oct-2019
17-Sep-2019	BC	Sub : Suspension of trading in equity shares -Artemis Global Life Sciences Limited In pursuance of Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A,it is	23-Oct-2019
14-Oct-2019	BC	With regard to the captioned matter we wish to inform you that the Special Committee of the Board of Directors of the Company at its meeting held on 14th October, 2019 have fixed the Record Date for	14-Oct-2019
28-Aug-2019	BC	AGM 30/09/2019 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015, now we wish to inform that the ninth Ann	30-Sep-2019
30-Sep-2019	BC	Dear Sir/ Madam, Pursuant to Regulation 30, Part-A of Schedule -III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that 9th Annual General Meetin	30-Sep-2019

No Rights has been declared by Artemis-Global-Life-Sciences-Ltd

Book Closure

Record Date	Split Date	Purpose
25-Oct-2019	-	Amalgamation
23-Oct-2019	-	Sub : Suspension of trading in equity shares -Artemis Global Life Sciences Limited In pursuance of Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A,it is
14-Oct-2019	-	With regard to the captioned matter we wish to inform you that the Special Committee of the Board of Directors of the Company at its meeting held on 14th October, 2019 have fixed the Record Date for
30-Sep-2019	-	AGM 30/09/2019 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015, now we wish to inform that the ninth Ann
30-Sep-2019	-	Dear Sir/ Madam, Pursuant to Regulation 30, Part-A of Schedule -III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that 9th Annual General Meetin

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Artemis Global Life Sciences Ltd((Merged) ₹49.45(0.00/0.00%)	49.45	+0.00	327.30	-30.84	0.00	2.07
Shalby Ltd ₹279.75(-3.85/-1.36%)	279.75	-3.85	3,021.57	97.35	30.30	2.97
Fortis Healthcare Ltd ₹443.55(-1.30/-0.29%)	443.55	-1.30	33,486.17	71.45	439.36	3.72
Poly Medicure Ltd ₹1,633.20(+49.15/3.10%)	1,633.20	+49.15	15,674.05	68.79	65.68	11.83
Mohini Health & Hygiene Ltd ₹58.60(+2.20/3.90%)	58.60	+2.20	106.86	16.73	15.63	1.19
GPT Healthcare Ltd ₹176.05(-1.35/-0.76%)	176.05	-1.35	1,444.58	0.00	29.67	6.79

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
Gross Sales	0.10	0.10	0.10	0.10	0.10	0.10
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.10	0.10	0.10	0.10	0.10	0.10
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.10	0.10	0.10	0.10	0.10	0.11
Total Expenditure	0.16	0.13	0.17	0.20	0.14	0.13
PBIDT	-0.06	-0.03	-0.07	-0.10	-0.04	-0.02
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.06	-0.03	-0.07	-0.10	-0.04	-0.02
Depreciation	0.04	0.04	0.04	0.04	0.04	0.04
Tax	0.00	0.00	0.00	0.00	0.00	0.12
Deferred Tax	0.02	-0.21	-0.02	-0.02	-0.02	0.00
Reported Profit After Tax	-0.12	0.15	-0.08	-0.12	-0.06	-0.18
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	-0.01
Adjusted Profit After Extra-ordinary item	-0.12	0.15	-0.08	-0.12	-0.06	-0.17

EPS (Unit Curr.)	-0.02	0.02	-0.01	-0.02	-0.01	-0.03
EPS (Adj) (Unit Curr.)	-0.02	0.02	-0.01	-0.02	-0.01	-0.03
Calculated EPS (Unit Curr.)	-0.02	0.02	-0.01	-0.02	-0.01	-0.03
Calculated EPS (Adj) (Unit Curr.)	-0.02	0.02	-0.01	-0.02	-0.01	-0.03
Calculated EPS (Ann.) (Unit Curr.)	-0.07	0.09	-0.05	-0.07	-0.04	-0.11
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-0.07	0.09	-0.05	-0.07	-0.04	-0.11
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	13.24	13.24	13.24	13.24	13.24	13.24
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-60.00	-30.00	-70.00	-100.00	-40.00	-20.00
PBDTM(%)	-60.00	-30.00	-70.00	-100.00	-40.00	-20.00
PATM(%)	-120.00	150.00	-80.00	-120.00	-60.00	-180.00

Column	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
Gross Sales	135.71	140.16	139.04	140.89	126.43	137.33
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	135.71	140.16	139.04	140.89	126.43	137.33
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.59	1.31	0.63	0.89	1.17	1.06
Total Income	136.30	141.47	139.66	141.78	127.60	138.39
Total Expenditure	120.91	122.25	121.92	123.83	114.71	111.76
PBIDT	15.39	19.22	17.74	17.96	12.89	26.63
Interest	3.28	2.88	3.10	2.99	2.03	2.59
PBDT	12.11	16.34	14.65	14.97	10.86	24.04
Depreciation	5.45	5.20	5.02	4.96	4.90	4.74
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	2.87	3.37	3.34	4.48	2.59	3.28
Deferred Tax	-0.48	2.30	1.38	-0.82	-0.29	0.04
Reported Profit After Tax	4.27	5.47	4.91	6.35	3.65	15.97
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	4.27	5.47	4.91	6.35	3.65	15.97

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	4.27	5.47	4.91	6.35	3.65	15.97

EPS (Unit Curr.)	0.64	0.84	0.74	0.96	0.55	2.41
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	13.24	13.24	13.24	13.24	13.24	13.24

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	11.34	13.71	12.76	12.75	10.20	19.39
PBDTM(%)	8.92	11.66	10.54	10.63	8.59	17.51
PATM(%)	3.15	3.90	3.53	4.51	2.89	11.63

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15	Mar 14
SOURCES OF FUNDS :
Share Capital	13.24	13.24	13.24	0.10	0.10	0.10
Reserves Total	145.18	145.30	145.60	0.02	-0.05	-0.04
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	158.42	158.54	158.84	0.12	0.05	0.06
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	158.42	158.54	158.84	0.12	0.05	0.06
APPLICATION OF FUNDS :
Gross Block	2.08	2.08	2.08	0.00	0.00	0.00
Less : Accumulated Depreciation	0.46	0.31	0.16	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1.62	1.77	1.92	0.00	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	159.91	159.91	159.91	0.00	0.05	0.05
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	0.11	0.00	0.00	0.00	0.00
Cash and Bank	0.00	0.09	0.52	0.13	0.01	0.01
Loans and Advances	0.00	0.00	0.01	0.07	0.00	0.00
Total Current Assets	0.00	0.20	0.53	0.20	0.01	0.01
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	3.28	3.23	3.25	0.00	0.01	0.01
Provisions	0.01	0.01	0.02	0.08	0.00	0.00
Total Current Liabilities	3.29	3.25	3.28	0.08	0.01	0.01
Net Current Assets	-3.29	-3.04	-2.75	0.12	0.00	0.01
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.28	0.19	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.13	0.32	0.24	0.00	0.00	0.00
Net Deferred Tax	0.15	-0.13	-0.24	0.00	0.00	0.00
Total Assets	158.39	158.51	158.84	0.12	0.05	0.06
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash and Cash Equivalents at Beginning of the year	0.09	0.52	0.13	0.01	0.01
Net Cash from Operating Activities	-0.09	-0.43	3.74	0.07	0.00
Net Cash Used In Investing Activities	0.00	0.00	0.00	0.05	0.00
Net Cash Used In Financing Activities	0.00	0.00	0.00	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	-0.09	-0.43	3.74	0.12	0.00
Cash And Cash Equivalents At End Of The Year	0.00	0.09	3.87	0.13	0.01

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

69.82%

FII Shareholding

0.00%

DII Shareholding

8.27%

Public Shareholding

21.59%

**Promoter pledged shareholding 69.82%

About Artemis Global Life Sciences Ltd((Merged)

Artemis Global Life Sciences Ltd((Merged) is in the Healthcare sector, having a market capitalization of Rs. 327.3 crores. It has reported a sales of Rs. 0.1 crores and a net profit of Rs. -0.12 crores for the quarter ended December 2018. The company management includes Onkar S Kanwar, Harish Bahadur,Devlina Chakravarty,Ugar Sain Anand,Neeraj Kanwar,Akshaykumar Chudasama,S Narayan,Sanjaya Baru,Onkar S Kanwar,Anuj Sood (Artemis Global Life Sciences Ltd((Merged)) among others.

Chairman

Onkar S Kanwar

Registered office

414/1 4th Floor District Centr,DDA Commer Complex Janakpuri,New Delhi,New Delhi,110058

FAX :91-11-4262306

Background

Incorporation Year2011

Face Value₹2

Market Lot1

How to buy Artemis Global shares on nse?

To buy Artemis Global shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Artemis Global share price today?

The Artemis Global shares price on nse is Rs.49.45 today.

What is the market cap of Artemis Global shares on NSE ?

The company has a market capitalization of Rs.327.30Cr

What is the PE & PB ratio of Artemis Global shares ?

PE is 0 and PB is 2.07

What is the 52 Week High and Low of Artemis Global shares?

Artemis Global stock price high: Rs.54.95 Artemis Global stock price low: Rs.0